Citadel Advisors
BMEZ icon

Citadel Advisors’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Citadel Advisors’s Portfolio BMEZ Stock Details BMEZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$237K Buy
+15,445
New +$222K ﹤0.01% 11665
2024
Q2 		– Sell
-16,677
Closed -$273K – 14279
2024
Q1 		$273K Sell
16,677
-12,721
-43% -$201K ﹤0.01% 9665
2023
Q4 		$431K Buy
+29,398
New +$410K ﹤0.01% 8423

Other funds holding BMEZ

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return

Citadel Advisors's BMEZ Position: Q2 2026 in Review

Citadel Advisors opened a new position in BlackRock Health Sciences Trust II (BMEZ) in Q2 2026: 15,445 shares worth $237K. The stake represents ﹤0.01% of the portfolio and ranks #11665 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in BMEZ as recently as Q1 2024.

Citadel Advisors first reported a position in BMEZ in Q4 2023 and has held it in 3 quarters since. The position peaked at $431K in Q4 2023. 88 funds tracked by Wall St. Rank hold BMEZ as of Q2 2026.

  • Citadel Advisors held 15,445 shares of BlackRock Health Sciences Trust II worth $237K as of Q2 2026.
  • BlackRock Health Sciences Trust II was a new Citadel Advisors position in Q2 2026.
  • BlackRock Health Sciences Trust II made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #11665 holding.
  • Citadel Advisors first reported a position in BlackRock Health Sciences Trust II in Q4 2023 and has held it in 3 quarters since.
  • Citadel Advisors's BlackRock Health Sciences Trust II position peaked at $431K in Q4 2023.
  • 88 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.